title: Designing immunotherapies to thwart drug abuse.
abstract: Immunotherapy for treating illicit drug abuse is a rapidly advancing field. There are currently two major approaches to developing drug-specific immunotherapies: active and passive. Active immunotherapy involves conjugating a drug-like hapten to a carrier protein and using traditional immunization approaches to generate a drug-specific immune response in the patient. In contrast, passive immunotherapy utilizes preformed monoclonal antibodies. Whether generated by active immunization or delivered passively, antibodies act as pharmacokinetic antagonists by binding the drug in the blood-stream and reducing the amount and rate of drug delivery to receptors in the brain. A newly emerging technology in anti-drug immunotherapy is the use of antibody fragments, or scFvs, rather than intact immunoglobulin G (IgG). These scFvs can retain the same binding properties as the original mAbs, and are onethird the molecular weight, providing a scaffold for creating antibody treatments with more customizable properties. Another nascent area of research utilizing the scFv scaffold is in creating drug-specific scFv-nanoparticle conjugates. These conjugates could improve upon current drug-specific antibody paradigms by increasing multivalency and allowing pharmacokinetic customization, while avoiding interactions with endogenous antibody receptor pathways. These parallel approaches to immunotherapy are moving rapidly toward the clinic and may soon provide new therapies for treating drug abuse.
authors: Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, 72205, USA. EPeterson@uams.edu
authors: Eric C
authors: EC
authors: Peterson
authors: S Michael
authors: SM
authors: Owens
mesh_terms: D000818:Animals; D015195:Drug Design; D006801:Humans; D007135:Immunoglobulin Variable Region / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use*; D007167:Immunotherapy / Q000191:economics; D019966:Substance-Related Disorders / Q000188:drug therapy* / Q000191:economics / Q000276:immunology*
chemical_list: D007135:Immunoglobulin Variable Region